Stocks and Investing
Stocks and Investing
Wed, January 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 2, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward White Reiterated (SNDX) at Strong Buy and Held Target at $41 on, Jan 2nd, 2024
Edward White of HC Wainwright & Co., Reiterated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $41 on, Jan 2nd, 2024.
Edward has made no other calls on SNDX in the last 4 months.
There are 6 other peers that have a rating on SNDX. Out of the 6 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Edward
- Mara Goldstein of "Mizuho" Initiated at Strong Buy and Held Target at $45 on, Friday, December 22nd, 2023
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Thursday, October 26th, 2023
- Jason Zemansky of "B of A Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, October 25th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $38 on, Tuesday, October 17th, 2023
- Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Wednesday, October 11th, 2023
- Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Tuesday, October 3rd, 2023
Contributing Sources